UNSPSC 51393106: Guanabenz monoacetate

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H8Cl2N4.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 443O19GK1A, chemically known as hydrazinecarboximidamide, 2-((2,6-dichlorophenyl)methylene)-, monoacetate, but more generally known as guanabenz monoacetate, which bears US NIH Compound Identifier 9570374. European Medicines Agency schedules guanabenz monoacetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07978MIG.

Most nations, for tariff purposes, schedule guanabenz monoacetate under HS 29280090. SMILES: CC(=O)O.C1CC(C(C(C1)CL)/C=N/NC(=N)N)CL.

UNSPSC 51393106 Guanabenz monoacetate is a Commodity code that shows little relevant recent activity under its nominal scope. The single opportunity in the recent record—Seminole County, Florida's IFB60459723LAS for Naloxone and Drug Deactivation Systems—is plainly unrelated to guanabenz monoacetate, an antihypertensive pharmaceutical with a distinct therapeutic indication. The mismatch between the code's stated product and the actual procurement signals either a tagging error in the source data or that guanabenz monoacetate does not currently drive state and local solicitation volume worth tracking for business development purposes.

Seminole County's naloxone procurement (IFB released June 30, 2026, with response deadline July 26, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to include shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify and drug-free workplace requirements, and meet federal compliance obligations tied to potential FEMA funding. The contract carried a two-year initial term with one-year renewal option and a three-month probationary period allowing termination at will. This opportunity reflects Florida county procurement activity but provides no actionable signal for guanabenz monoacetate positioning, as the code appears to carry either incorrect recent tagging or minimal current state and local demand.